共 83 条
[1]
Miyata K(2011)Polymeric micelles for nano-scale drug delivery React Funct Polym 71 227-234
[2]
Christie RJ(2007)Comparison of the solubility and dissolution rate between gliclazide solid complex and its nanospheres Drug Dev Ind Pharm 33 301-309
[3]
Kataoka K(2012)pH-sensitive polymeric nanoparticles to improve oral bioavailability of peptide/protein drugs and poorly water-soluble drugs Eur J Pharm Biopharm 82 219-229
[4]
Lo Y(1992)The mode of action and clinical pharmacology of gliclazide: a review Diabetes Res Clin Pract 14 S21-S36
[5]
Chen C(1991)Evaluation of the efficacy and safety of Diamicron® in non-insulin-dependent diabetic patients Diabetes Res ClinPract 2 S79-82
[6]
Tsai T(2012)Overcoming poor oral bioavailability using nanoparticle formulations – opportunities and limitations Drug Dis Today: Technologies 9 e87-e95
[7]
Wang XQ(2000)Gliclazide modified release: from once-daily administration to 24-hour blood glucose control Metab Clin Exp 49 7-11
[8]
Zhang Q(2010)Design and evaluation of a novel formulation prediction system Int J Pharm 402 129-139
[9]
Campbell DB(1998)Accelerated oral absorption of gliclazide in human subjects from a soft gelatin capsule containing a PEG 400 suspension of gliclazide J Control Rel 51 185-192
[10]
Lavielle R(2010)Single non-ionic surfactant based self-nanoemulsifying drug delivery systems: formulation, characterization, cytotoxicity and permeability enhancement study Powder Technol 197 150-158